WebMD56m
FDA Approves New Drug for Advanced Lung Cancer
The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).
The American Journal of Managed Care23h
Ensartinib Receives FDA Approval for ALK-Positive Locally Advanced or Metastatic NSCLC
The FDA has approved ensartinib in adult patients with anaplastic lymphoma kinase (ALK)–positive locally advanced or ...
Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer
Researchers at the Icahn School of Medicine at Mount Sinai have identified the mechanism of action of a treatment for ...
What we just found out about the possible tie between microplastics and cancer
New research published Wednesday in the journal Environmental Science and Technology offers evidence that microplastics are ...
eLife1d
Chemotherapy resistance due to epithelial-to-mesenchymal transition is caused by abnormal lipid metabolic balance
This paper presents the important discovery that lipid metabolic imbalance caused by Snail, an EMT-related transcription factor, contributes to the acquisition of chemoresistance in cancer cells.
Science News2d
Cancer screening and quitting smoking have saved nearly 6 million lives
Prevention, screening and treatment advances combined stopped 5.94 million deaths from cancer in the United States from 1975 through 2020.